Literature DB >> 26674359

Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.

Stefania Varchetta1, Dalila Mele1, Andrea Lombardi2, Barbara Oliviero1, Stefania Mantovani1,2, Carmine Tinelli3, Marta Spreafico4, Daniele Prati4, Serena Ludovisi2, Giovanna Ferraioli5, Carlo Filice5, Alessio Aghemo6, Pietro Lampertico6, Floriana Facchetti6, Francesca Bernuzzi7, Pietro Invernizzi7, Mario U Mondelli1,2.   

Abstract

OBJECTIVE: Sialic-acid-binding immunoglobulin-like lectin-7 (Siglec-7) is a natural killer (NK) cell inhibitory receptor associated with NK phenotypic and functional abnormalities in HIV-1 infection. We investigated the significance of NK-expressed and serum soluble Siglec-7 in relation to NK functional ability and parameters of liver necroinflammation and fibrosis in chronic HCV infection.
DESIGN: NK-expressed and serum Siglec-7 were evaluated in 130 and 166 HCV-infected individuals by flow cytometry and ELISA, respectively. NK cell degranulation and cytokine secretion were determined by flow cytometry. 65 patients with chronic HBV infection, 84 with chronic biliary disorders and 168 healthy donors served as controls.
RESULTS: Expression of Siglec-7 was significantly decreased on NK cells from HCV-infected and HBV-infected patients and, conversely, serum Siglec-7 was significantly increased in these patients compared with controls. The frequency of Siglec-7pos NK cells was significantly higher at baseline in sustained virological responders to pegylated interferon-α/ribavirin treatment than in non-responders. Activating receptor expression was significantly higher in Siglec-7pos NK cells and was associated with increased degranulation and cytokine secretion compared with Siglec-7neg cells. In chronic HCV infection, there was an inverse correlation between Siglec-7 expression and serum aminotransferases, γ-glutamyl transpeptidase, liver stiffness, aspartate aminotransferase to platelet ratio index and fibrosis-4 scores, and a positive correlation between serum Siglec-7 and the same clinical parameters, including histological staging.
CONCLUSIONS: These findings identify Siglec-7neg NK cells as a dysfunctional subpopulation associated with severe liver disease in chronic HCV infection. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  CELLULAR IMMUNOLOGY; FIBROSIS; HEPATITIS B; HEPATITIS C; LIVER IMMUNOLOGY

Mesh:

Substances:

Year:  2015        PMID: 26674359     DOI: 10.1136/gutjnl-2015-310327

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  DNA methylation-mediated Siglec-7 regulation in natural killer cells via two 5' promoter CpG sites.

Authors:  Hsin-Ting Huang; Shih-Chi Su; Tzeon-Jye Chiou; Yen-Hsi Lin; Yi-Chen Shih; Yu-Xuan Wu; Ting-Hsi Fan; Yuh-Ching Twu
Journal:  Immunology       Date:  2020-03-05       Impact factor: 7.397

2.  Siglec-7 on peripheral blood eosinophils: Surface expression and function.

Authors:  Fanny Legrand; Nadine Landolina; Ilan Zaffran; Robert O Emeh; Elizabeth Chen; Amy D Klion; Francesca Levi-Schaffer
Journal:  Allergy       Date:  2019-02-26       Impact factor: 13.146

3.  Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.

Authors:  L Tao; S Wang; L Yang; L Jiang; J Li; X Wang
Journal:  Clin Exp Immunol       Date:  2020-05-17       Impact factor: 4.330

4.  Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.

Authors:  Christopher W Pohlmeyer; Veronica D Gonzalez; Alivelu Irrinki; Ricardo N Ramirez; Li Li; Andrew Mulato; Jeffrey P Murry; Aaron Arvey; Rebecca Hoh; Steven G Deeks; George Kukolj; Tomas Cihlar; Stefan Pflanz; Garry P Nolan; Gundula Min-Oo
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

5.  Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.

Authors:  Andrew S Allegretti; Guillermo Ortiz; Sahir Kalim; Joshua Wibecan; Dongsheng Zhang; Hui Yi Shan; Dihua Xu; Raymond T Chung; S Ananth Karumanchi; Ravi I Thadhani
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

6.  Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  Jiexiong Xie; Isaura Christiaens; Bo Yang; Wander Van Breedam; Tingting Cui; Hans J Nauwynck
Journal:  J Gen Virol       Date:  2017-07-26       Impact factor: 3.891

7.  Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.

Authors:  Philip Rosenstock; Rüdiger Horstkorte; Vinayaga Srinivasan Gnanapragassam; Jörg Harth; Heike Kielstein
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

Review 8.  Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates.

Authors:  Joanna Mikulak; Clara Di Vito; Elisa Zaghi; Domenico Mavilio
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

9.  Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication.

Authors:  Di Zhao; Xuemei Jiang; Yong Xu; Huimin Yang; Dongni Gao; Xueen Li; Lifen Gao; Chunhong Ma; Xiaohong Liang
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

Review 10.  Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry.

Authors:  Benjamin Shibru; Katharina Fey; Stephan Fricke; André-René Blaudszun; Friederike Fürst; Max Weise; Sabine Seiffert; Maria Katharina Weyh; Ulrike Köhl; Ulrich Sack; Andreas Boldt
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.